5/8/2023AZ and MSD's Koselugo Gets Chinese Approval for Rare Genetic Disorder ...

5/5/2023Recent Executive Moves

5/5/2023NMPA Begins a New Round of Comment Seeking on the Provisions on Drug S...

5/5/2023Junshi Biosciences and Dr. Reddy's Enter Exclusive License Pact for To...

5/4/2023AstraZeneca Places Bet on COPD as COVID Vaccine Sales Fade

5/4/2023Roche Disposes China Rights of Rocephin to Hasten Biopharma

5/4/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (69...

5/4/2023ChP Commission Publicizes Chinese Generic Names of Biologics in the WH...

5/4/2023NIFDC Solicits Public Comments on Revision of the Guidelines for Drug ...

5/3/202319 EU Member States Seek to Reduce Dependency on Chinese APIs

5/3/2023CDE Solicits Comments on Implementation Suggestions for ICH Guidelines...

5/3/2023CDE Issues the Technical Guidelines for Clinical R&D of Anti-Tumor Pho...

5/2/2023Shunxi Licences Cartherics's CAR-T Cell Therapy for Ovarian Cancer in ...

5/2/2023CBMG and Janssen Enter License Deal to Develop and Commercialize anti...

4/28/2023Recent Executive Moves

4/28/2023Financial-related Company News Digest (April 2023)

4/28/2023Drug R&D and Product Registration News Digest April 2023 (4)

4/28/2023Central Government Initiates Campaign to Crackdown on BMI Related Frau...

4/28/2023NMPA Announces OTC Switch of Four Rx Drug Products

4/28/2023AstraZeneca Eyes More China Deals After Signing Three Licensing Deals

Page:32/32 Total number of articles:950: [First][<<] [28] [29] [30] [31] [32] [>>] [End]